AI assistant
Senti Biosciences, Inc. — Director's Dealing 2026
Feb 3, 2026
34717_dirs_2026-02-03_4aaa93f4-1f86-4ed8-a77d-73a278568965.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Senti Biosciences, Inc. (SNTI)
CIK: 0001854270
Period of Report: 2026-02-02
Reporting Person: Lu Timothy K (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | Common Stock | F | 4191 | — | Disposed | 720249 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 52839 | Indirect |
| Common Stock | 52839 | Indirect |
Footnotes
F1: Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale.
F2: The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.